XM does not provide services to residents of the United States of America.

TSX tumbles to three-week low; still posts monthly gain



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>CANADA STOCKS-TSX tumbles to three-week low; still posts monthly gain</title></head><body>

TSX ends down 1.43% at 24,156.87

For the month, the TSX gains 0.65%

Materials group falls 2.4% as gold drops

Tech loses 2.8 with Open Text down 11.1%

Updates at market close

By Nikhil Sharma and Fergal Smith

Oct 31 (Reuters) -Canada's main stock index gave back much of its monthly gain on Thursday as it fell to a three-week low in a wider selloff that was led by technology shares.

The Toronto Stock Exchange's S&P/TSX composite index .GSPTSE ended down 350.92 points, or 1.43%, at 24,156.87, its lowest closing level since Oct. 8. For the month, the index was up 0.65%, its fourth straight monthly increase.

"The run that the market's had lately ... a pullback is expected," said Michael Constantino, CEO of Webull Canada.

U.S. stocks slumped after Microsoft and Meta Platforms highlighted growing artificial intelligence costs that could affect their earnings, curbing enthusiasm for megacap stocks that have fueled the market rally this year.

"It's unusual for the Canadian market to totally detach from the U.S. on a short-term basis," said Brian Madden, chief investment officer at First Avenue Investment Counsel. "So, selling pressure in the U.S. taints the sentiment in Canada."

The materials group, which includes fertilizer companies and metal mining shares, fell 2.4% as gold pulled back from a record high. Still, the index has climbed more than 30% since the start of 2024.

"We're still seeing some client interest in financials and materials," Webull Canada's Constantino said. "They've been winners all year so clients are still picking their spots."

Financials were down 1.4% on Thursday, while technology ended 2.8% lower as Open Text Corp OTEX.TO lost 11.1% after reporting quarterly revenue that missed analysts' estimates.

Energy fell 1.2%, with Cenovus Energy Inc CVE.TO down 3.4% after posting a 56% slump in third-quarter profit due to a decline in production.

Bausch Health Companies Inc BHC.TO was a bright spot, with its shares jumping 12.7% after the drugmaker reported stronger-than-expected third-quarter earnings.



Reporting by Fergal Smith in Toronto and Nikhil Sharma in Bengaluru; Editing by Vijay Kishore and Diane Craft

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.